VECTIBIX
Google image searchProduct monograph
Active ingredient
panitumumab, 400 MG/20 ML
DIN: 02308509
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 03-JAN-2017
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FE — EGFR (Epidermal Growth Factor Receptor) inhibitors (ATC, ATC/DDD)
- L01FE02 — PANITUMUMAB (ATC/DDD)
Reference brand drug: Vectibix
